METABOLIC AGENTS IN THE TREATMENT OF ALCOHOLISM AND DIFFERENT CENTRAL NERVOUS SYSTEM DISEASES


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

The paper considers the possibilities of a threonine and pyridoxine combination used to treat different central nervous system diseases, as well as Biotredin® to relieve alcohol withdrawal syndrome with a predominance of psychopathological and somatic disorders for disactualization of pathological alcohol craving and for physical and mental stabilization in alcoholics in remission.

全文:

受限制的访问

作者简介

V. Kukes

I.M. Sechenov First Moscow State Medical University

Email: a.s.zhestovskaia@gmail.com
Professor Moscow

A. Zhestovskaya

I.M. Sechenov First Moscow State Medical University

Email: a.s.zhestovskaia@gmail.com
Moscow

Ya. Nartsissov

Research Institute of Cytochemistry and Molecular Pharmacology

Email: a.s.zhestovskaia@gmail.com
Candidate of Physicomathematical Sciences Moscow

E. Tyukina

Research Institute of Cytochemistry and Molecular Pharmacology

Email: a.s.zhestovskaia@gmail.com
Moscow

E. Sheshegova

Research Institute of Cytochemistry and Molecular Pharmacology

Email: a.s.zhestovskaia@gmail.com
Candidate of Pharmaceutical Sciences Moscow

参考

  1. Афанасьев В.В. Алкогольный абстинентный синдром. Монография / Интермедика, 2002.
  2. Москвичев В.Г. Диагностика и лечение алкогольного абстинентного синдрома // Лечащий врач. - 2004; 03/04: 70-3.
  3. Островский Ю.М. и др. Метаболические предпосылки и последствия потребления алкоголя / Минск: Наука и техника, 1988; 233 с.
  4. http://biotredin.ru/
  5. Cooper J. Nutrition and the brain: what advice should we give? // Neurobiol. Aging. - 2014; 35 (Suppl. 2): 79-83.
  6. Умарова Х.Я., Чугунов А.В., Казаков А.Ю. Применение Биотредина в практике невролога // Доктор.Ру. - 2014; 6-1 (94): 49-52.
  7. Takei N., Nawa H. mTOR signaling and its roles in normal and abnormal brain development // Front. Mol. Neurosci. - 2014; 7: 28-33.
  8. Rehberg K., Kliche S., Madencioglu D. et al. The serine/threonine kinase Ndr2 controls integrin trafficking and integrindependentneurite growth // J. Neurosci. - 2014; 34 (15): 5342-54.
  9. Hankey G., Ford A., Yi Q. et al. Effect of B vitamins and lowering homocysteine on cognitive impairment in patients with previous stroke or transient ischemic attack: a prespecified secondary analysis of a randomized, placebo-controlled trial and meta-analysis // Stroke. - 2013; 44 (8): 2232-9.
  10. Caram-Salas N., Reyes-Garcia G., Medina-Santillân R. et al. Thiamine and cyanocobalamin relieve neuropathic pain in rats: synergy with dexamethasone // Pharmacology. - 2006; 77 (2): 53-62.
  11. Kuwabara S., Nakazawa R., Azuma N. et al. Intravenous methylcobalamin treatment for uremic and diabetic neuropathy in chronic hemodialysis patients // Intern. Med. - 1999; 38 (6): 472-5.
  12. Dolina S., Margalit D., Malitsky S. et al. Attention-deficit hyperactivity disorder (ADHD) as a pyridoxine-dependent condition: urinary diagnostic biomarkers // Med. Hypotheses. - 2014; 82 (1): 111-6.
  13. Pangilinan P., Giacoletti-Argento A., Shellhaas R. et al. Neuropharmacology in pediatric brain injury: a review // PMR. - 2010; 2 (12): 1127-40.
  14. Tazoe M., Ichikawa K., Hoshino T. Biosynthesis of vitamin B6 in Rhizobium: in vitro synthesis of pyridoxine from 1-deoxy-D-xylulose and 4-hydroxy-L-threonine // Biosci. Biotechnol. Biochem. - 2002; 66 (4): 934-6.
  15. Государственный реестр лекарственных средств. Биотредин. URL: http://grls.rosminzdrav.ru (дата обращения: 01.03.2014).
  16. Гусев Е.И., Комиссарова И.А., Алферова В.В. и др. Опыт применения метаболитного комплекса препаратов Глицин, Биотредин, Лимонтар в терапии ишемического инсульта // Terra Medica. - 2001; 4: 37-8.
  17. Джумагазиев А.А., Белопасов В.В., Рахимова Л.Р. Применение метаболитов у детей с перинатальными гипоксически-ишемическими поражениями ЦНС. VII Российский национальный конгресс «Человек и лекарство» / М., 2000; с. 346.

补充文件

附件文件
动作
1. JATS XML

版权所有 © Russkiy Vrach Publishing House, 2016